SANES

10.004

+0.12%↑

BBVA

19.775

+1.38%↑

ALV

390.1

+1.17%↑

MUV2

557.2

+1.24%↑

INGA

23.945

+0.99%↑

SANES

10.004

+0.12%↑

BBVA

19.775

+1.38%↑

ALV

390.1

+1.17%↑

MUV2

557.2

+1.24%↑

INGA

23.945

+0.99%↑

SANES

10.004

+0.12%↑

BBVA

19.775

+1.38%↑

ALV

390.1

+1.17%↑

MUV2

557.2

+1.24%↑

INGA

23.945

+0.99%↑

SANES

10.004

+0.12%↑

BBVA

19.775

+1.38%↑

ALV

390.1

+1.17%↑

MUV2

557.2

+1.24%↑

INGA

23.945

+0.99%↑

SANES

10.004

+0.12%↑

BBVA

19.775

+1.38%↑

ALV

390.1

+1.17%↑

MUV2

557.2

+1.24%↑

INGA

23.945

+0.99%↑

Search

Equasens

Fechado

43 -1.71

Visão Geral

Variação de preço das ações

24h

Atual

Mín

42.5

Máximo

43.75

Indicadores-chave

By Trading Economics

Rendimento

-1.8M

17M

Vendas

7.2M

116M

P/E

Médio do Setor

18.515

Rendimento de Dividendos

2.87

Margem de lucro

14.879

Funcionários

1,400

EBITDA

178M

116M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

2.87%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

58M

665M

Abertura anterior

44.71

Fecho anterior

43

Equasens Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de dez. de 2025, 23:54 UTC

Ações em Alta

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 de dez. de 2025, 23:51 UTC

Ganhos

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 de dez. de 2025, 23:39 UTC

Grandes Movimentos do Mercado

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 de dez. de 2025, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 de dez. de 2025, 21:40 UTC

Ganhos

Nike Sales Tick Up, But China Weakness Persists

18 de dez. de 2025, 23:45 UTC

Conversa de Mercado

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 de dez. de 2025, 23:37 UTC

Conversa de Mercado
Ganhos

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 de dez. de 2025, 23:36 UTC

Conversa de Mercado

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 de dez. de 2025, 23:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 de dez. de 2025, 23:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 de dez. de 2025, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 de dez. de 2025, 22:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 de dez. de 2025, 22:58 UTC

Aquisições, Fusões, Aquisições de Empresas

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 de dez. de 2025, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 de dez. de 2025, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 de dez. de 2025, 22:55 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:59 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

18 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

18 de dez. de 2025, 21:35 UTC

Ganhos

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 de dez. de 2025, 21:31 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Greater China Rev Down 17% >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q EPS 53c >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Apparel Rev $3.91B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Equipment Rev $550M >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q N Amer Rev $5.63B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Footwear Rev $7.66B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Greater China Rev $1.42B >NKE

Comparação entre Pares

Variação de preço

Equasens Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Equasens

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat